885453-49-6 Usage
General Description
4-Bromo-2-chloro-6-fluoro-phenylamine is a chemical compound with the molecular formula C6H4BrClFN. It is a member of the phenylamine family and is derived from benzene. 4-Bromo-2-chloro-6-fluoro-phenylamine is characterized by the presence of bromine, chlorine, and fluorine atoms attached to the phenyl ring, and it is commonly used as a building block in the synthesis of various pharmaceuticals and organic compounds. It is also known for its potential use in the development of agrochemicals and as a reagent in organic chemistry reactions. Additionally, 4-Bromo-2-chloro-6-fluoro-phenylamine has been the subject of research in the field of medicinal chemistry due to its interesting pharmacological properties. Overall, this compound possesses a diverse range of applications and exhibits potential for further study in various scientific disciplines.
Check Digit Verification of cas no
The CAS Registry Mumber 885453-49-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,4,5 and 3 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 885453-49:
(8*8)+(7*8)+(6*5)+(5*4)+(4*5)+(3*3)+(2*4)+(1*9)=216
216 % 10 = 6
So 885453-49-6 is a valid CAS Registry Number.
885453-49-6Relevant articles and documents
ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS
-
Page/Page column 81, (2018/02/28)
The present invention relates to a compound of the general formula (1), wherein the pyranose ring is alpha-D-galactopyranose, A is selected from (2), and (3). The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore, the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
NOVEL BICYCLIC HETEROCYCLIC COMPOUND
-
Page/Page column 73, (2011/11/07)
The present invention aims to provide a drug for the treatment or prophylaxis of pathology in general in which SNS is involved, specifically diseases such as neuropathic pain, nociceptive pain, dysuria, multiple sclerosis and the like. The present inventi
HIV INHIBITING BICYCLIC PYRIMIDINE DERIVATIVES
-
Page/Page column 51, (2010/11/08)
HIV replication inhibitors of formula (I) N-oxides, pharmaceutically acceptable addition salts, quaternary amines or stereoisomeric forms thereof, wherein -a1=a2-a3=a4- is -CH=CH-CH=CH-, -N=CH-CH=CH-, -N=CH-N=CH
